Literature DB >> 10918597

The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.

M Bemark1, M S Neuberger.   

Abstract

Burkitt's lymphomas harbour chromosomal translocations bringing c-MYC into the vicinity of one of the immunoglobulin gene loci. Point mutations have been described within c-MYC in several Burkitt's lymphomas and it has been proposed that translocation into the Ig loci might have transformed c-MYC into a substrate for the antibody hypermutation mechanism. Here we test this hypothesis by exploiting a Burkitt's lymphoma line (Ramos) that we have previously shown to hypermutate its immunoglobulin genes constitutively. We find that, during in vitro culture, Ramos mutates the c-MYC allele that is translocated into the IgH locus whilst leaving the untranslocated c-MYC and other control genes essentially unaffected. The mutations are introduced downstream of the c-MYC transcription start with the pattern of substitutions being characteristic of the antibody hypermutation mechanism; the mutation frequency is 2-3-fold lower than for the endogenous functional IgH allele. Thus chromosomal translocations involving the Ig loci may not only contribute to transformation by deregulating oncogene expression but could also act by potentiating subsequent oncogene hypermutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918597     DOI: 10.1038/sj.onc.1203686

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  In vivo and in vitro studies of immunoglobulin gene somatic hypermutation.

Authors:  J E Sale; M Bemark; G T Williams; C J Jolly; M R Ehrenstein; C Rada; C Milstein; M S Neuberger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  Somatic hypermutation of the AID transgene in B and non-B cells.

Authors:  Alberto Martin; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-29       Impact factor: 11.205

3.  Genomic uracil homeostasis during normal B cell maturation and loss of this balance during B cell cancer development.

Authors:  Sophia Shalhout; Dania Haddad; Angela Sosin; Thomas C Holland; Ayad Al-Katib; Alberto Martin; Ashok S Bhagwat
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

Review 4.  DNA lesions and repair in immunoglobulin class switch recombination and somatic hypermutation.

Authors:  Zhenming Xu; Zsolt Fulop; Yuan Zhong; Albert J Evinger; Hong Zan; Paolo Casali
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

5.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Authors:  Sietse M Aukema; Markus Kreuz; Christian W Kohler; Maciej Rosolowski; Dirk Hasenclever; Michael Hummel; Ralf Küppers; Dido Lenze; German Ott; Christiane Pott; Julia Richter; Andreas Rosenwald; Monika Szczepanowski; Carsten Schwaenen; Harald Stein; Heiko Trautmann; Swen Wessendorf; Lorenz Trümper; Markus Loeffler; Rainer Spang; Philip M Kluin; Wolfram Klapper; Reiner Siebert
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

6.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication.

Authors:  Hye-Ra Lee; Sultan Doğanay; Brian Chung; Zsolt Toth; Kevin Brulois; Stacy Lee; Zhansaya Kanketayeva; Pinghui Feng; Taekjip Ha; Jae U Jung
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

7.  Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.

Authors:  Michael T Hemann; Anka Bric; Julie Teruya-Feldstein; Andreas Herbst; Jonas A Nilsson; Carlos Cordon-Cardo; John L Cleveland; William P Tansey; Scott W Lowe
Journal:  Nature       Date:  2005-08-11       Impact factor: 49.962

8.  Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.

Authors:  Paula L Miliani de Marval; Everardo Macias; Robert Rounbehler; Piotr Sicinski; Hiroaki Kiyokawa; David G Johnson; Claudio J Conti; Marcelo L Rodriguez-Puebla
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 9.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

Review 10.  Immunoglobulin somatic hypermutation: double-strand DNA breaks, AID and error-prone DNA repair.

Authors:  Xiaoping Wu; Junli Feng; Atsumasa Komori; Edmund C Kim; Hong Zan; Paolo Casali
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.